跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SODIUM NITROPRUSSIDE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
SODIUM NITROPRUSSIDE FOR INJECTION
Authorized
STANDARD
SODIUM NITROPRUSSIDE FOR INJECTION
Sterimax Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
79e9b0db52ed09f7
Company
Sterimax Inc
Type
Standard
Approval Details
Approval Id
79e9b0db52ed09f7
Drug Approval Canada Name
SODIUM NITROPRUSSIDE FOR INJECTION
Product Name
SODIUM NITROPRUSSIDE FOR INJECTION
Status
Marketed
Status Date
2021-04-26
Original Market Date
2021-04-26
Din
02450089
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous
Schedule
Prescription
Ahfs
24:08.20
Atc Original
C02DD01 NITROPRUSSIDE
Atc Name
c 02 dd 01
Aig Number
0110498002
Company Name
Sterimax Inc
Company Address
2770 Portland Drive, Oakville, Ontario, Canada, L6H 6R4
Active Ingredients
SODIUM NITROPRUSSIDE
25 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
79e9b0db52ed09f7
Type
Standard
Back to Health Canada Approvals